WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bruce N. JacobsChief Financial Officer2026-06-0212,653$2.08
$26.32kBuy
Jeremy G. ChadwickChief Operating Officer2026-05-27600$82.08
$49.25kSell
Jeremy G. ChadwickChief Operating Officer2026-05-273,679$81.50
$299.85kSell
Jeremy G. ChadwickChief Operating Officer2026-05-263,800$79.39
$301.69kSell
Jeremy G. ChadwickChief Operating Officer2026-05-263,730$78.36
$292.27kSell
Jeremy G. ChadwickChief Operating Officer2026-05-26324$79.17
$25.65kSell
Jeremy G. ChadwickChief Operating Officer2026-05-26551$80.71
$44.47kSell
Jeremy G. ChadwickChief Operating Officer2026-05-264,500$80.03
$360.11kSell
Pamela EspositoDirector2026-05-191,000$31.20
$31.20kBuy
Bruce N. JacobsChief Financial Officer2026-05-1815,000$2.08
$31.20kBuy

1 of 17

KYMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.22%11,699,950$899.84MInstitution
Baker Bros Advisors LP10.52%8,657,242$665.83MInstitution
Baker Bros Advisors LP9.67%7,955,916$611.89MInsider
Avoro Capital Advisors LLC9.09%7,474,747$574.88MInstitution
Price T Rowe Associates Inc7.37%6,060,847$466.14MInstitution
Atlas Venture Associates X LP7.01%5,763,012$443.23MInsider
Atlas Venture Fund X LP6.69%5,504,905$423.38MInsider
Bvf Inc6.69%5,502,710$423.21MInstitution
T Rowe Price Investment Management Inc6.64%5,464,997$420.31MInstitution
Blackrock Inc6.15%5,060,876$389.23MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR78.23%21.77%Net BuyingNet Selling
IMVT48.10%51.90%Net BuyingNet Selling
LEGN25.86%0.15%Net SellingNet Selling
SYRE76.31%23.69%Net SellingNet Selling
PCVX89.00%11.00%Net SellingNet Selling
View Top Biotech Stocks

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 117.06% institutional shareholders, 32.58% Kymera Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Kymera Therapeutics shareholder, owning 7.96M shares representing 9.67% of the company. Baker Bros Advisors LP's Kymera Therapeutics shares are currently valued at $622.39M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.